𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological response

✍ Scribed by T. Carlsson; O. Reichard; G. Norkrans; J. Bläckberg; P. Sangfelt; E. Wallmark; O. Weiland

Book ID
108885784
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
147 KB
Volume
12
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Twelve weeks posttreatment follow-up is
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin
✍ Michelle Martinot-Peignoux; Christiane Stern; Sarah Maylin; Marie-Pierre Ripault 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

A sustained virologic response (SVR) in patients with chronic hepatitis C receiving pegylated interferon (PEG-IFN) plus ribavirin is defined as undetectable serum HCV-RNA at 24 weeks (W+24) posttreatment follow-up. Viral load outcome in patients with virological relapse (VR) has not been explored. T

Variants in interferon-alpha pathway gen
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may